Neurolixis
's headquarters is in Dana Point, California. Neurolixis has 3 followers on Owler. Neurolixis has an estimated revenue of <$1M and an estimate of less <10 employees.Neurolixis
's headquarters is in Dana Point, California. Neurolixis has 3 followers on Owler. Neurolixis has an estimated revenue of <$1M and an estimate of less <10 employees.
CEO
Add
Est. Annual Revenue
<$1M
Est. Employees
<10
News
Mar 18, 2025
EIN Presswire
Press Release: Neurolixis : Neurolixis Publishes Positive Phase 2A Trial Results for NLX-112 in Parkinson's Disease
Sep 25, 2024
EIN Presswire
Press Release: Neurolixis : Neurolixis Secures Orphan Medicinal Product Designation for NLX-112 as a Treatment for Spinocerebellar Ataxia
Jun 27, 2023
EIN Presswire
Press Release: Neurolixis : Neurolixis to present results of successful NLX-112 proof-of-concept clinical trial at the World Parkinson's Congress
Mar 20, 2023
EIN Presswire
Press Release: Neurolixis : Neurolixis Announces Positive Ph2A Proof-of-Concept on NLX-112 in Levodopa-Induced Dyskinesia in Parkinson's Disease
Nov 30, 2021
EIN Presswire
Press Release: Neurolixis : First Patient Dosed in Phase 2a Trial of NLX-112 for the Treatment of L-DOPA Induced Dyskinesia in Parkinson's Disease
Mar 02, 2020
Pharmafile
Neurolixis: Experimental drug could treat dyskinesia in people with Parkinson's
Oct 19, 2018
BioPortfolio
Neurolixis: Neurolixis Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 12092018 Prices from USD $250
Jan 26, 2018
PharmiWeb
Neurolixis: Non-profit to accelerate development of potential new Parkinson's drug
Jan 25, 2018
PharmaTimes
Neurolixis: UK charity gives US biotech $1m for Parkinson's research
Feb 21, 2016
PRLog
Press Release: Neurolixis : Neurolixis Announces Publications Demonstrating Effects of NLX-112 in Parkinson Disease Models